Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 43 entries
Sorted by: Best Match Show Resources per page
Erratum to: platinum-based chemotherapy in triple-negative advanced breast cancer.

Breast cancer research and treatment

Villarreal-Garza C, Khalaf D, Bouganim N, Clemons M, Peña-Curiel O, Baez-Revueltas B, Kiss A, Kassam F, Enright K, Verma S, Pritchard K, Myers J, Dent R.
PMID: 25809091
Breast Cancer Res Treat. 2015 Apr;150(3):697. doi: 10.1007/s10549-015-3345-z.

No abstract available.

Pharmacogenetics of response to neoadjuvant paclitaxel treatment for locally advanced breast cancer.

Oncotarget

Perez-Ortiz AC, Ramírez I, Cruz-López JC, Villarreal-Garza C, Luna-Angulo A, Lira-Romero E, Jiménez-Chaidez S, Díaz-Chávez J, Matus-Santos JA, Sánchez-Chapul L, Mendoza-Lorenzo P, Estrada-Mena FJ.
PMID: 29290962
Oncotarget. 2017 Nov 15;8(63):106454-106467. doi: 10.18632/oncotarget.22461. eCollection 2017 Dec 05.

Locally advanced breast cancer (LABC) cases have a varying five-year survival rate, mainly influenced by the tumor response to chemotherapy. Paclitaxel activity (response rate) varies across populations from 21.5% to 84%. There are some reports on genetic traits and...

Impaired Cerebral Vasomotor Reactivity in Alzheimer's Disease.

International journal of Alzheimer's disease

Gongora-Rivera F, Cordero-Perez A, Gonzalez-Aquines A, Anaya-Escamilla A, Villarreal-Garza E, Espinosa-Ortega M, Salinas-Carmona MC, Ortiz-Jimenez X.
PMID: 30271632
Int J Alzheimers Dis. 2018 Sep 09;2018:9328293. doi: 10.1155/2018/9328293. eCollection 2018.

BACKGROUND: Recent studies have shown that cerebral vascularity may be impaired in Alzheimer's disease. Cerebral vasomotor reactivity could be an important biomarker for this pathology.AIMS: The aim of this study was to investigate the alterations in cerebral vascular motor...

Ovarian Function and Fertility Preservation in Breast Cancer: Should Gonadotropin-Releasing Hormone Agonist be administered to All Premenopausal Patients Receiving Chemotherapy?.

Clinical medicine insights. Reproductive health

Lambertini M, Richard F, Nguyen B, Viglietti G, Villarreal-Garza C.
PMID: 30886529
Clin Med Insights Reprod Health. 2019 Mar 09;13:1179558119828393. doi: 10.1177/1179558119828393. eCollection 2019.

Chemotherapy-induced premature ovarian insufficiency (POI) is one of the potential drawbacks of chemotherapy use of particular concern for newly diagnosed premenopausal breast cancer patients. Temporary ovarian suppression obtained pharmacologically with the administration of a gonadotropin-releasing hormone agonist (GnRHa) during...

Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis.

European journal of cancer (Oxford, England : 1990)

Becerril-Gaitan A, Vaca-Cartagena BF, Ferrigno AS, Mesa-Chavez F, Barrientos-Gutiérrez T, Tagliamento M, Lambertini M, Villarreal-Garza C.
PMID: 34794855
Eur J Cancer. 2021 Oct 26; doi: 10.1016/j.ejca.2021.10.014. Epub 2021 Oct 26.

BACKGROUND: Patients with cancer are considered a priority group for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccination given their high risk of contracting severe Coronavirus Disease 2019 (COVID-19). However, limited data exist regarding the efficacy of immunisation in...

Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor Behavior.

Cancers

Rodríguez-Bautista R, Caro-Sánchez CH, Cabrera-Galeana P, Alanis-Funes GJ, Gutierrez-Millán E, Ávila-Ríos S, Matías-Florentino M, Reyes-Terán G, Díaz-Chávez J, Villarreal-Garza C, Hernández-Pedro NY, Ortega-Gómez A, Lara-Mejía L, Rangel-Escareño C, Arrieta O.
PMID: 34944876
Cancers (Basel). 2021 Dec 13;13(24). doi: 10.3390/cancers13246256.

Triple-negative breast cancer (TNBC) is an aggressive and heterogeneous disease. Seven subtypes have been described based on gene expression patterns. Herein, we characterized the tumor biology and clinical behavior of the immunomodulatory (IM) subtype.METHODS: Formalin-fixed paraffin-embedded tumor samples from...

Positron emission mammography in the evaluation of interim response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.

Cancer treatment and research communications

Soldevilla-Gallardo I, Villaseñor-Navarro Y, Medina-Ornelas SS, Villarreal-Garza C, Bargalló-Rocha E, Caro-Sánchez CH, Gallardo-Alvarado LN, Hernández-Ramírez R, Arela-Quispe LM, García-Pérez FO.
PMID: 31298999
Cancer Treat Res Commun. 2018;16:24-31. doi: 10.1016/j.ctarc.2018.05.001. Epub 2018 May 14.

Neoadjuvant chemotherapy (NAC) has an important role in patients with locally advanced cancers, treating distant micrometastases, downstaging tumors, improving operability, and sometimes allowing breast-conserving surgery to take place. We studied the association between two Positron Emission Mammography with AIM:...

Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis.

European journal of cancer (Oxford, England : 1990)

Becerril-Gaitan A, Vaca-Cartagena BF, Ferrigno AS, Mesa-Chavez F, Barrientos-Gutiérrez T, Tagliamento M, Lambertini M, Villarreal-Garza C.
PMID: 34794855
Eur J Cancer. 2021 Oct 26; doi: 10.1016/j.ejca.2021.10.014. Epub 2021 Oct 26.

BACKGROUND: Patients with cancer are considered a priority group for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccination given their high risk of contracting severe Coronavirus Disease 2019 (COVID-19). However, limited data exist regarding the efficacy of immunisation in...

Safety of assisted reproductive techniques in young women harboring germline pathogenic variants in BRCA1/2 with a pregnancy after prior history of breast cancer.

ESMO open

Condorelli M, Bruzzone M, Ceppi M, Ferrari A, Grinshpun A, Hamy AS, de Azambuja E, Carrasco E, Peccatori FA, Di Meglio A, Paluch-Shimon S, Poorvu PD, Venturelli M, Rousset-Jablonski C, Senechal C, Livraghi L, Ponzone R, De Marchis L, Pogoda K, Sonnenblick A, Villarreal-Garza C, Córdoba O, Teixeira L, Clatot F, Punie K, Graffeo R, Dieci MV, Pérez-Fidalgo JA, Duhoux FP, Puglisi F, Ferreira AR, Blondeaux E, Peretz-Yablonski T, Caron O, Saule C, Ameye L, Balmaña J, Partridge AH, Azim HA, Demeestere I, Lambertini M.
PMID: 34775302
ESMO Open. 2021 Nov 11;6(6):100300. doi: 10.1016/j.esmoop.2021.100300. Epub 2021 Nov 11.

BACKGROUND: Knowledge is growing on the safety of assisted reproductive techniques (ART) in cancer survivors. No data exist, however, for the specific population of breast cancer patients harboring germline BRCA1/2 pathogenic variants.PATIENTS AND METHODS: This is a multicenter retrospective...

Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis.

European journal of cancer (Oxford, England : 1990)

Becerril-Gaitan A, Vaca-Cartagena BF, Ferrigno AS, Mesa-Chavez F, Barrientos-Gutiérrez T, Tagliamento M, Lambertini M, Villarreal-Garza C.
PMID: 34794855
Eur J Cancer. 2022 Jan;160:243-260. doi: 10.1016/j.ejca.2021.10.014. Epub 2021 Oct 26.

BACKGROUND: Patients with cancer are considered a priority group for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccination given their high risk of contracting severe Coronavirus Disease 2019 (COVID-19). However, limited data exist regarding the efficacy of immunisation in...

Adherence to Adjuvant Tamoxifen in Mexican Young Women with Breast Cancer.

Patient preference and adherence

Martinez-Cannon BA, Castro-Sanchez A, Barragan-Carrillo R, de la Rosa Pacheco S, Platas A, Fonseca A, Vega Y, Bojorquez-Velazquez K, Bargallo-Rocha JE, Mohar A, Villarreal-Garza C.
PMID: 34040357
Patient Prefer Adherence. 2021 May 19;15:1039-1049. doi: 10.2147/PPA.S296747. eCollection 2021.

BACKGROUND: Breast cancer (BC) in young women is characterized by an unfavorable prognosis in hormone receptor-positive/HER2-negative tumors, which may be explained by low rates of tamoxifen adherence. In Mexico, up to 14% of all BC diagnoses occur in young...

Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis.

European journal of cancer (Oxford, England : 1990)

Becerril-Gaitan A, Vaca-Cartagena BF, Ferrigno AS, Mesa-Chavez F, Barrientos-Gutiérrez T, Tagliamento M, Lambertini M, Villarreal-Garza C.
PMID: 34794855
Eur J Cancer. 2022 Jan;160:243-260. doi: 10.1016/j.ejca.2021.10.014. Epub 2021 Oct 26.

BACKGROUND: Patients with cancer are considered a priority group for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccination given their high risk of contracting severe Coronavirus Disease 2019 (COVID-19). However, limited data exist regarding the efficacy of immunisation in...

Showing 1 to 12 of 43 entries